Astera Labs Surges on AI Demand, but Valuation Cushion Vanishes

What happened

Astera Labs shares have climbed 27.5% since late May, pushing the price to $442 and reflecting strong AI-driven sales momentum. The rally follows Q1 revenue growth of 93% YoY and upbeat guidance, but the stock now trades at a P/E of 280x with no margin of safety. The DeepValue report maintains a WAIT rating, noting that at this price the base-case value of $430 offers minimal upside and the bear case of $280 looms if margin or Scorpio ramp disappoints. The key catalysts—Scorpio production in 2H26 and gross margin stability near 73%—remain unproven, and customer concentration at 29% from one account adds risk. The market has priced in a flawless execution scenario, leaving little room for error.

Implication

Long-term investors should monitor Q2 results and Scorpio progress; failure to deliver could trigger a sharp re-rating toward $280, while success may only yield modest gains from here.

Thesis delta

The stock has overshot the base-case value of $430, making the risk/reward unattractive. The rally was driven by AI momentum and narrative, but fundamental margin and concentration risks remain unaddressed. Investors should treat the current price as a sell signal for longs and wait for a lower entry.